Aldeyra Therapeutics, Inc.
News
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Shares Sold by Los Angeles Capital Management LLC
Zolmax Los Angeles Capital Management LLC lessened its holdings in shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX - Free Report) by 12.1% during the second quarter, HoldingsChannel reports. The fund...\n more…
Los Angeles Capital Management LLC Decreases Stake in Aldeyra Therapeutics, Inc (NASDAQ:ALDX)
Ticker Report Los Angeles Capital Management LLC decreased its holdings in shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX - Free Report) by 12.1% in the 2nd quarter, according to the company in its most recent...\n more…
Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Business Wire Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today...\n more…
Aldeyra Therapeutics Announces Executive Team Changes
TipRanks Financial Blog An update from Aldeyra Therapeutics (ALDX) is now available. Aldeyra Therapeutics, Inc. has announced the appointment of Michael Alfieri as the new principal financ...\n more…
SG Americas Securities LLC Makes New $38,000 Investment in Aldeyra Therapeutics, Inc (NASDAQ:ALDX)
Ticker Report SG Americas Securities LLC bought a new position in shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the...\n more…
Aldeyra Therapeutics Has Data To Trigger AbbVie Partnership
SeekingAlpha Aldeyra Therapeutics Has Data To Trigger AbbVie Partnership...\n more…